Structure Therapeutics (GPCR) Change in Account Payables (2022 - 2026)

Structure Therapeutics' Change in Account Payables history runs 5 years deep, the most recent figure standing at -$5.0 million for Q1 2026.

• In Q1 2026, Change in Account Payables fell 824.05% year-over-year to -$5.0 million; the TTM figure through Mar 2026 stood at -$888000.0 (down 140.85% YoY), while the FY2025 annual figure was $4.8 million, up 44.09% from the prior year.
• Change in Account Payables was -$5.0 million for Q1 2026 at Structure Therapeutics, up from -$5.0 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $8.8 million in Q3 2025 to a low of -$5.0 million in Q4 2025.
• Historically, Change in Account Payables has averaged $258705.9 across 5 years, with a median of $280000.0 in 2025.
• The sharpest annual moves came in 2023 and 2025: Change in Account Payables jumped 1227.42% in 2023, then slumped 1083.69% in 2025.
• A 5-year view of Change in Account Payables shows it stood at -$124000.0 in 2022, then surged by 1227.42% to $1.4 million in 2023, then sank by 130.26% to -$423000.0 in 2024, then plunged by 1083.69% to -$5.0 million in 2025, then advanced by 0.8% to -$5.0 million in 2026.
• The last three Change in Account Payables figures came in at -$5.0 million (Q1 2026), -$5.0 million (Q4 2025), and $8.8 million (Q3 2025), per Business Quant data.